3828725
Synthesis of N-substituted quinazoline-4-amine and N 2,N 4 -disubstituted quinazoline-2,4-diamine derivatives as adenosine/guanosine nucleoside ribohydrolase inhibitors in trichomoniasis
Date
March 29, 2023
Related Products
Synthesis and evaluation of biaryl compounds as inhibitors of nucleoside hydrolases to treat trichomoniasis
Trichomoniasis is the most prevalent non-viral sexually transmitted diseases. It is caused by the parasitic protozoan _Trichomonas vaginalis_. Current treatments use 5-nitroimidazoles to damage DNA residues, but due to increasing resistance over time, there is a need for a novel treatment. _T…
Computational design of trichomonas vaginalis purine nucleoside hydrolase inhibitors | Poster Board #3260
Trichomoniasis is a non-viral sexually transmitted disease caused by infection with the protozoan parasite _Trichomonas vaginalis_. In recent years the parasite has evolved increasing resistance to its current treatment with 5-nitroimidazole drugs. _T…
Concerted use of molecular modeling and parasitology to guide design of novel Trichomonas vaginalis nucleoside ribohydrolase inhibitors
_Trichomonas vaginalis_ is a protozoan parasite that causes trichomoniasis, a sexually transmitted disease which may lead to harmful complications. Current treatment regimens rely on metronidazole or related 5-nitroimidazole compounds…
Investigating a Novel method of dynthesizing alpha,alpha- difluoronitriles | Poster Board #674
The presence of a fluorine is common in biological molecules in pharmaceuticals and agrochemicals. Its importance stems from a variety of reasons including increasing metabolic stability and changing the lipophilicity as well as modifying the acidity and basicity of nearby functional groups…